MolMed

    OverviewSuggest Edit

    MolMed is a biotechnology company focused on research, development and clinical validation of novel antitumour therapies. MolMed's pipeline includes two novel therapeutics in clinical development: TK, a cell- based therapy enabling bone marrow transplants from partially compatible donors, in Phase III in high-risk acute leukaemia; NGR-hTNF, a novel vascular targeting agent, in Phase III in malignant pleural mesothelioma and in Phase II in six more indications: colorectal, lung (small-cell and non-small-cell), liver and ovarian cancer, and soft tissue sarcomas. MolMed also offers expertise in cell and gene therapy to third parties to develop, conduct and validate projects from preclinical to Phase III trials, including scale-up and cGMP production of clinical-grade viral vectors, and manufacturing of patient-specific genetically engineered cells. 
    TypePublic
    Founded1996
    HQMilano, IT
    Websitemolmed.com

    Latest Updates

    Employees (est.) (Dec 2017)186

    MolMed Office Locations

    MolMed has an office in Milano
    Milano, IT (HQ)
    58 Via Olgettina Milano
    Show all (1)

    MolMed Online and Social Media Presence

    Embed Graph

    MolMed Blogs

    ASGCT Annual Meeting 2019

    Scientific Apr 29, 2019 - May 2, 2019 Location:  Washington DC (USA) MolMed at this event:  Presentation: Implementation of iCELLis® Technology for the Manufacture of Lentiviral vectors IT

    MolMed l'officina dei superfarmaci

    Apr 16, 2019 Page cover:  Il Sole 24 Ore publishes an article on MolMed, in which is described the activities of development and production of gene and cell therapies in its facilities, with an interview with Riccardo Palmisano, Giuliana Vallanti and Michele Manfredini. Attachment:  molmed_sole_…

    World Advanced Therapies & Regenerative Medicine Congress Terrapinn

    Scientific May 15, 2019 - May 17, 2019 Location:  London, UK MolMed at this event:  Silver Sponsor. Giuliana Vallanti Conference: Friday 17th May 2019 VIRAL VECTOR MANUFACTURE 11:45 TBC: Technology for safe and effective viral vector manufacture Reserved MolMed EN

    ARM annual Meeting on the MED

    Scientific Apr 23, 2019 - Apr 24, 2019 Location:  Barcelona, Spain MolMed at this event:  PANEL: THE PRICING AND REIMBURSEMENT LANDSCAPE: OPPORTUNITIES AND CHALLENGES Luca Alberici, Ph.D., Chief Business Officer, MolMed EN

    CS_Disponibilità verbale assemblea 25.10 e dello Statuto sociale aggiornato

    Press release file:  3473_1542389991.pdf Publication Date and time:  Nov 16, 2018 EN

    Stage QA Compliance

    Attività principali: Nell'ambito nel Quality Assurance apprendere come gestire la documentazione relativa ai training del personale e relativa archiviazione; Fornire supporto nella stesura, revisione, diffusione e archiviazione delle Procedure Operative Standard; Apprendere le Norme di …
    Show more

    MolMed Frequently Asked Questions

    • When was MolMed founded?

      MolMed was founded in 1996.

    • How many employees does MolMed have?

      MolMed has 186 employees.

    • Who are MolMed competitors?

      Competitors of MolMed include Rakuten Medical, Karo Pharma and Alligator Bioscience.

    • Where is MolMed headquarters?

      MolMed headquarters is located at 58 Via Olgettina Milano, Milano.

    • Where are MolMed offices?

      MolMed has an office in Milano.

    • How many offices does MolMed have?

      MolMed has 1 office.